$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Targeted gas and gaseous precursor-filled liposomes 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-049/04
출원번호 US-0942862 (1997-10-02)
발명자 / 주소
  • Unger Evan C.
  • Fritz Thomas A.
  • Matsunaga Terry
  • Ramaswami VaradaRajan
  • Yellowhair David
  • Wu Guanli
출원인 / 주소
  • ImaRx Pharmaceutical Corp.
대리인 / 주소
    Woodcock Washburn Kurtz Mackiewicz & Norris LLP
인용정보 피인용 횟수 : 177  인용 특허 : 217

초록

Methods of and apparatus for preparing temperature activated gaseous precursor-filled liposomes are described. Gaseous precursor-filled liposomes prepared by these methods are particularly useful, for example, in ultrasonic imaging applications and in therapeutic drug delivery systems.

대표청구항

[ What is claimed is:] [1.] A microsphere comprising a lipid, a targeting moiety and at least one of a first gas or a gaseous precursor, wherein said microsphere is a liposome and encapsulates at least a portion of said first gas, said gaseous precursor, or both, to provide at least about 75% volume

이 특허에 인용된 특허 (217)

  1. Moore Dennis A. (Ferguson MO) Adams Max D. (St. Charles MO) Cacheris William P. (Florissant MO) White David H. (Ballwin MO) Periasamy Muthunadar P. (Chesterfield MO) Rajagopalan Raghavan (Maryland He, 19F magnetic resonance imaging agents which include a nitroxide moiety.
  2. Lanza Gregory M. (Evanston IL) Onyuksel M. Hayat (LaGrange IL) Klegerman Melvin E. (Chicago IL) Vonesh Michael J. (Northbrook IL) McPherson David L. (Chicago IL), Acoustically reflective liposomes and methods to make and use same.
  3. Lanza Gregory M. ; Alkan-Onyuksel M. Hayat ; Klegerman Melvin E. ; McPherson David D. ; Kane Bonnie J. ; Murer Sasha E., Acoustically reflective liposomes and methods to make and use the same.
  4. Spitzer Joseph G. (Mamaroneck NY) Osipow Lloyd (New York NY), Aerosol astringent composition.
  5. Nicolau Yves-Claude (La Chapelle FRX) Le Pape Alain (Langeais FRX) Barot-Ciorbaru Rita (Fontenay-Aux-Roses FRX), Aerosol composition for in vivo imaging.
  6. Abra Robert (San Francisco CA) Guo Luke S. S. (Lafeyette CA), Amphotericin B/cholesterol sulfate composition and method.
  7. Messina Ralph P. (Somerset NJ), Antiperspirants formulated with borax.
  8. Dory Jacques (91 ; rue des Molveaux 77450 Coupvray-Esblay FRX), Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatme.
  9. Cook Edward J. (South Hamilton MA) Lagace Arthur P. (Newtonville MA), Apparatus for forming emulsions.
  10. Heldebrant Charles M. (Arcadia CA) Crowe Kim C. (Northridge CA) Groveman George R. (Clairmont CA) Davis ; Jr. Charles H. (Mission Viejo CA), Apparatus for oxygenation of liquid state dissolved oxygen-carrying formulation.
  11. Sekins K. Michael (San Diego CA) Shaffer Thomas H. (Lansdowne PA) Wolfson Marla R. (Wyndmoor PA), Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation.
  12. Talish Roger J. (Fairfield NJ) Ryaby John P. (Essex Fells NJ) Scowen Kenneth J. (Springfield NJ) Urgovitch Kenneth J. (Clifton NJ), Apparatus for ultrasonic bone treatment.
  13. Carter Charles P. (301 SW. 46 Oklahoma City OK 73109), Automatic fence picket stock conveyor for fence picket pointing machine.
  14. Long ; Jr. David M. (El Cajon CA), Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal.
  15. Gref Ruxandra (Nancy FRX) Minamitake Yoshiharu (Brookline MA) Langer Robert S. (Newton MA), Biodegradable injectable particles for imaging.
  16. Jay Michael J. (Lexington KY) Ryo U. Yun (Lexington KY), Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging.
  17. Tachibana Katsuro (6-18 ; Kusagae 1-chome ; Chuo-ku Fukuoka-shi ; Fukuoka 810 JPX) Tachibana Shunro (6-18 ; Kusagae 1-chome ; Chuo-ku Fukuoka-shi ; Fukuoka 810 JPX), Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same.
  18. Long ; Jr. David M. (El Cajon CA), Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport.
  19. Gordon Robert T. (4936 W. Estes Skokie IL 60076), Cancer treatment by intracellular hyperthermia.
  20. Hilmann Juergen (Berlin DEX) Hoffmann Rolf-Ruediger (Berlin DEX) Muetzel Wolfgang (Berlin DEX) Zimmermann Ingfried (Berlin DEX), Carrier liquid solutions for the production of gas microbubbles, preparation thereof, and use thereof as contrast medium.
  21. Grinstaff Mark W. (Pasadena CA) Soon-Shiong Patrick (Los Angeles CA) Wong Michael (Champaign IL) Sandford Paul A. (Los Angeles CA) Suslick Kenneth S. (Champaign IL) Desai Neil P. (Los Angeles CA), Composition useful for in vivo delivery of biologics and methods employing same.
  22. Higgins William A. (Gates Mills OH) Bretz John (Parma OH), Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing.
  23. Widder Kenneth J. (Del Mar CA) Westkaemper Peter J. (San Diego CA), Concentrated stabilized microbubble-type ultrasonic imaging agent.
  24. Feinstein Steven B. (295 Hasting Ave. Highland Park IL 60035), Contact agents for ultrasonic imaging.
  25. Cerny David (Chula Vista CA) Mills Gary J. (San Diego CA) Westkaemper Peter J. (San Diego CA), Continuous sonication method for preparing protein encapsulated microbubbles.
  26. Schneider David R. (Birmingham MI) Bis Kostaki G. (Troy MI), Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess an.
  27. Klaveness Jo (Oslo NOX) Priebe Hanno (Oslo NOX) Rongved Pal (Nesoddtanger NOX) Stubberud Lars (Sdertlje SEX), Contrast agents.
  28. Klaveness Jo (Oslo NOX) Rongved Pal (Nesoddtaugen NOX) Strande Per (Oslo NOX), Contrast agents.
  29. Gamble Ronald C. (Altadena CA) Schmidt Paul G. (San Marino CA), Contrast agents for NMR imaging.
  30. Feinstein Steven B. (295 Hasting Ave. Highland Park IL 60035), Contrast agents for ultrasonic imaging.
  31. Yudelson Joseph S. (Rochester) Power Susan E. (Rochester NY), Contrast agents for ultrasound imaging.
  32. Klaveness Jo (Olso NOX) Rongved Pl (Hellvik NOX) Stubberud Lars (Sodertalje SEX), Contrast agents, consisting of galactose particles and an amphilic carboxylic acid.
  33. Mackaness George B. (Princeton NJ) Hou Joseph P. (Kendall Park NJ), Contrast media containing liposomes as carriers.
  34. Rssling Georg (Berlin DEX) Albayrak Celal (Berlin DEX) Rothe Matthias (Berlin DEX) Siegert Joachim (Berlin DEX), Contrast media synthesized from polyaldehydes.
  35. Weichselbaum Ralph R. (2031 N. Sedgwick Chicago IL 60616) Hallahan Dennis E. (5343 N. Moody Chicago IL 60630) Sukhatme Vikas P. (1511 E. 56th St. Chicago IL 60637) Kufe Donald W. (179 Grove St. Welle, Control of gene expression by ionizing radiation.
  36. Supersaxo Andreas (Basel CA CHX) Kou Jim H. (Palo Alto CA), Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles.
  37. Stindl Wolfgang (Eisenstadt ATX) Zimmerman Ingfried (Berlin DEX) Reckers Renate (Berlin DEX) Wendt Hans (Berlin DEX) Arndt Rainold (Berlin DEX), Corticoid-containing preparation for topical application.
  38. Do-huu Jean-Paul (Paris FRX) Hartemann Pierre (Paris FRX), Device for localized heating of biological tissues.
  39. Lele Padmakar P. (Winchester MA), Diffuse focus ultrasound hyperthermia system.
  40. Long ; Jr. David M. (San Diego CA), Dissolution of gas in a fluorocarbon liquid.
  41. Lohrmann Rolf (La Jolla CA) Widder Kenneth J. (Rancho Santa Fe CA) Krishnan Ashwin M. (San Diego CA) Hong Dung K. (San Diego CA) Meng Jialun (San Diego CA), Emulsions as contrast agents and method of use.
  42. Lohrmann Rolf ; Widder Kenneth J. ; Krishnan Ashwin M. ; Hong Dung Kevin ; Meng Jialun, Emulsions as contrast agents and method of use.
  43. Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO), Emulsions of highly fluorinated organic compounds.
  44. Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO), Emulsions of highly fluorinated organic compounds.
  45. Cullis Pieter R. (Vancouver CAX) Hope Michael J. (Vancouver CAX) Bally Marcel B. (Vancouver CAX), Extrusion technique for producing unilamellar vesicles.
  46. Klaveness Jo (Oslo NOX) Priebe Hanno (Oslo NOX) Rongved Pl (Nesoddtauger NOX) Stubberud Lars (Sodertalje SEX), Flexible amphiphilic microbubbles for ultrasound.
  47. Riess Jean G. (Falicon FRX) Jeanneaux Francois (Nice FRX) Krafft Marie-Pierre (Nice FRX) Santaella Catherine (Nice FRX) Vierling Pierre (Falicon FRX), Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties.
  48. Kirkland W. Dean (El Cajon CA), Fluorocarbon contrast media for use with MRI and radiographic imaging.
  49. Bailey Austin L. (Vancouver CAX) Cullis Pieter R. (Vancouver CAX), Fusogenic lipsomes and methods for making and using same.
  50. Henderson Sheryl L. (Weare NH) Wallach Donald F. H. (Hollis NH) Mathur Rajiv (Nashua NH), Gas and oxygen carrying lipid vesicles.
  51. Kabalnov Alexey ; Schutt Ernest George ; Weers Jeffry Greg, Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients.
  52. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749) Wu Guanli (2602 W. Aiden St. Tucson AZ 85745), Gas filled liposomes and their use as ultrasonic contrast agents.
  53. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749) Wu Guanli (2602 W. Aiden St. Tucson AZ 85745), Gas filled liposomes and their use as ultrasonic contrast agents.
  54. Yan Feng (Carouge CHX) Schneider Michel (Troinex CHX) Brochot Jean (Feigeres FRX), Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method.
  55. Lohrmann Rolf (La Jolla CA), Gas-filled microspheres with fluorine-containing shells.
  56. Cohen Smadar (Petach-Tickva MA ILX) Andrianov Alexander K. (Belmont MA) Wheatley Margaret (Media PA) Allcock Harry R. (State College PA) Langer Robert S. (Newton MA), Gas-filled polymeric microbubbles for ultrasound imaging.
  57. Klaveness Jo (Oslo NOX) Rongved Pl (Nesoddtangen NOX) Strande Per (Oslo NOX), Gaseous microparticles as ultrasound contrast agents.
  58. Quay Steven C. (Pacific Palisades CA), Gaseous ultrasound contrast media.
  59. Day Delbert E. (Rolla MO) Ehrhardt Gary J. (Columbia MO), Glass microspheres.
  60. Schutt Ernest G. (San Diego CA), Harmonic ultrasound imaging with microbubbles.
  61. Geho W. Blair (Wooster OH) Lau John R. (Wooster OH), Hepatocyte Directed Vesicle delivery system.
  62. Kim Sinil (Solana Beach CA), Heterovesicular liposomes.
  63. West ; III Glenn (San Carlos CA) Martin Francis J. (San Francisco CA), High-concentration liposome processing method.
  64. Sands, Bruce W.; Nehring, Jr., Robert J., Hollow microspheres with organosilicon-silicate walls.
  65. Meybeck Alain (Courbevoie FRX) Bonte Frederic (Boulogne FRX), Hydrated lipidic lamellar phases or liposomes based on ecdysteroids.
  66. Cole Francis X. (Stow MA), Immunoassay products and methods.
  67. Klaveness Jo (Skoyen Terrasse NOX) Strande Per (Nordengveien NOX), Iodinated esters.
  68. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Ionophore containing liposomes for ultrasound imaging.
  69. Baldeschwieler John D. (Pasadena CA) Gamble Ronald C. (Pasadena CA) Mauk Marcia R. (Vancouver NJ CAX) Shen Tsung-Ying (Westfield NJ) Ponpipom Mitree M. (Branchburg NJ), Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances.
  70. Ryan Patrick J. (Worcester MA) Davis Michael A. (Westwood MA) Melchior Donald L. (Framingham MA), Lipisomes containing gas for ultrasound detection.
  71. Chapman Dennis (Beaconsfield GB2) Hayward James A. (London GB2), Liposome composition as gas transport agents.
  72. Martin Francis J. (San Francisco CA) Morano Jacqueline K. (Mountain View CA), Liposome extrusion method.
  73. Mannino Raphael J. (Box 404 Newtonville NY 12128) Fogerite Susan G. (112 Third St. Waterford NY 12188), Liposome methods and compositions.
  74. Klaveness Jo (Oslo NOX) Berg Arne (Sandvika NOX) Jacobsen Trond Vegard (Oslo NOX) Rongved Pal (Nesoddtangen NOX) Ege Thorfinn (Tranby NOX) Kikuchi Hiroshi (Tokyo JPX) Yachi Kiyoto (Tokyo JPX), Liposomes.
  75. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same.
  76. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same.
  77. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same.
  78. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same.
  79. Ryan, Patrick J.; Davis, Michael A.; Melchior, Donald L., Liposomes containing modified cholesterol for organ targeting.
  80. Axelsson Bengt I. (Genarp SEX) Brattsand Ralph L. (Lund SEX) Dahlbck Carl M. O. (Lund SEX) Kllstrm Leif A. (Sdra Sandby SEX) Trofast Jan W. (Lund SEX), Liposomes containing steroid esters.
  81. Allen Theresa M. (Edmonton CAX) Martin Francis J. (San Francisco CA), Liposomes for treatment of B-cell and T-cell disorders.
  82. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Yau-Young Annie (Los Altos CA) Redemann Carl T. (Walnut Creek CA), Liposomes with enhanced circulation time.
  83. Lambert Karel J. (San Diego CA) Jablonski Edward G. (Escondido CA), Liquid core microdroplets for ultrasound imaging.
  84. Schneider Michel (Troinex CHX) Yan Feng (Geneva CHX) Grenier ; deceased Pascal (late of Ambilly FRX by Nadine Garcel ; legal heir ) Puginier Jerome (Le Chable-Beaumont FRX) Barrau Marie-Bernadette (G, Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the prepa.
  85. Schneider Michel (Troinex CHX) Yan Feng (Genve CHX) Grenier ; deceased Pascal (late of Ambilly FRX by Nadine Garcel ; legal heir) Puginier Jrme (Le Chble-Beaumont FRX) Barrau Marie-Bernadette (Geneva, Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the prepa.
  86. Unger Evan C. (Tucson AZ), Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applicati.
  87. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Low density microspheres and their use as contrast agents for computed tomography.
  88. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Low density microspheres and their use as contrast agents for computed tomography.
  89. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Low density microspheres and their use as contrast agents for computed tomography.
  90. Unger Evan C. (Tucson AZ), Low density microspheres and their use as contrast agents for computed tomography, and in other applications.
  91. Cline Harvey E. (Schenectady NY) Ettinger Robert H. (Schenectady NY) Rohling Kenneth W. (Burnt Hills NY) Watkins Ronald D. (Niskayuna NY), Magnetic resonance guided focussed ultrasound surgery.
  92. Albert Mitchell S. (Shoreham NY) Balamore Dilip (Shoreham NY) Cates ; Jr. Gordon D. (Skillman NJ) Driehuys Bastiaan (Bristol PA) Happer William (Princeton NJ) Saam Brian (Princeton NJ) Wishnia Arnold, Magnetic resonance imaging using hyperpolarized noble gases.
  93. Desai Neil P. (Los Angeles CA) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Grinstaff Mark W. (Pasadena CA) Suslick Kenneth S. (Champaign IL), Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell.
  94. Long David M. (El Cajon CA), Magnetic resonance imaging with perfluorocarbon hydrides.
  95. Morris Robert M. (Franklin IN), Magnetically-localizable, biodegradable lipid microspheres.
  96. Sands Bruce W. (Malvern PA), Manufacturing process for hollow microspheres.
  97. Sands Bruce W. (Malvern PA), Manufacturing process for hollow microspheres.
  98. Baldeschwieler John D. (Pasadena CA) Gamble Ronald C. (Pasadena CA) Mauk Marcia R. (Vancouver CAX), Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species.
  99. Radhakrishnan Ramachandran (Fremont CA) Mihalko Paul J. (Fremont CA) Abra Robert M. (San Francisco CA), Method and apparatus for administering dehydrated liposomes by inhalation.
  100. Drewes William (100 Ellison Ave. Bronxville NY 10708) Levine Martin (Hastings-on-Hudson NY), Method and apparatus for selective cell destruction.
  101. Aida Satoshi (Tokyo JPX) Shibata Mariko (Kanagawa JPX) Fujimoto Katsuhiko (Kanagawa JPX) Ishibashi Yoshiharu (Tokyo JPX) Suzuki Takuji (Kanagawa JPX) Sato Kozo (Kanagawa JPX) Itoh Ayao (Kanagawa JPX), Method and apparatus for ultrasonic wave medical treatment using computed tomography.
  102. Pierschbacher Michael D. (San Diego CA) Cheng Soan (San Diego CA) Craig William S. (San Diego CA) Tschopp Juerg F. (San Diego CA), Method and composition for treating thrombosis.
  103. Gordon Robert T. (4936 W. Estes Skokie IL 60076), Method for enhancing NMR imaging; and diagnostic use.
  104. Garner Joseph L. (Sanford MI) Tiffany Peter A. (Midland MI), Method for expanding microspheres and expandable composition.
  105. Duarte Luiz R. (Rua Campos Sales 2099 Sao Paulo BRX 13560), Method for healing bone fractures with ultrasound.
  106. Arai Toshiyuki (26-46 Nishifukunokawa-cho Okazaki ; Sakyo-ku ; Kyoto 606 NY JPX) Gupte Pradeep M. (3 Larissa Ct. Tallman ; Monsey NY 10952) Lasker Sigmund E. (531 Main St. New York NY 10044), Method for introducing oxygen-17 into tissue for imaging in a magnetic resonance imaging system.
  107. Lambert Karel J. ; Podell Sheila Benay ; Jablonski Edward G. ; Hulle Carl ; Hamilton Kenneth ; Lohrmann Rolf, Method for making encapsulated gas microspheres from heat denatured protein in the absence of oxygen gas.
  108. Quay Steven C. (Pacific Palisades CA), Method for preparing storage stable colloids.
  109. Fulwyler Mack J. (Los Alamos NM) Hatcher C. William (Los Alamos NM), Method for producing uniform particles.
  110. Grinstaff Mark W. (Pasadena CA) Desai Neil P. (Los Angeles CA) Suslick Kenneth S. (Champaign IL) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Merideth Noma R. (Pacific Palis, Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging.
  111. Giddey Claude (Geneva CHX) Dove Georges (Carouge CHX), Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography.
  112. D\Arrigo Joseph S. (Farmington CT), Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and the.
  113. Barenholz Yechezkel (Jerusalem ILX) Haran Gilad (Jerusalem ILX), Method of amphiphatic drug loading in liposomes by ammonium ion gradient.
  114. Barenolz Yechezkel (Jerusalem ILX) Haran Gilad (Jerusalem ILX), Method of amphiphatic drug loading in liposomes by pH gradient.
  115. Olson Camilla (4143 Hubbartt Dr. Palo Alto CA 94306), Method of assessing placentation.
  116. Ishihara Ken (1-1-15 Chigusa ; Takarazuka-shi ; Hyogo JPX), Method of controlling drug release by resonant sound wave.
  117. Bonsen Pieter (Los Altos CA) Wong Patrick S. (Kowloon CA HKX) Theeuwes Felix (Los Altos CA), Method of delivering drug with aid of effervescent activity generated in environment of use.
  118. Tickner Ernest G. (Morgan Hill CA), Method of determining pressure within liquid containing vessel.
  119. Leunbach Ib (Dragr DKX), Method of electron spin resonance enhanced magnetic resonance imaging.
  120. Ohno Tsuneya (Boston MA) Weichselbaum Ralph R. (Chicago IL) Kufe Donald W. (Wellesley MA), Method of inducing gene expression by ionizing radiation.
  121. Widder Kenneth J. (Del Mar CA) Barnhart James L. (Encinitas CA), Method of magnetic resonance imaging using diamagnetic contrast.
  122. Lambert Karel J. (San Diego CA) Jablonski Edward G. (Escondido CA) Hulle Carl (San Diego CA), Method of making encapsulated gas microspheres useful as an ultrasonic imaging agent.
  123. Bichon Daniel,FRX ; Bussat Philippe,FRX ; Schneider Michel,CHX, Method of making polymeric gas or air filled microballoons for ultrasonic echography.
  124. Akselrod Solange (Givat Shmuel ILX) Mor-Avi Victor (Kiryat Ono ILX) David Daniel (Raanana ILX), Method of measuring regional tissue blood flow.
  125. Unger Evan C. (Tucson AZ) Fritz Thomas A. (Tucson AZ) Matsunaga Terry (Tucson AZ) Ramaswami VaradaRajan (Tucson AZ) Yellowhair David (Tucson AZ) Wu Guanli (Tucson AZ), Method of preparing gas and gaseous precursor-filled microspheres.
  126. Netting David I. (Springfield PA) Hertzenberg Elliot P. (Wilmington DE), Method of preparing modified hollow, largely spherical particles by spray drying.
  127. Iga Katsumi (Suita JPX) Hamaguchi Naoru (Ibaraki JPX) Ogawa Yasuaki (Ibaraki JPX), Method of producing liposome.
  128. Lencki Robert W. J. (1650 Lincoln Ave. ; Apt. 1101 Montreal ; Quebec CAX H3H 1H1) Neufeld Ronald J. (110 Westbank Ave. Pointe Claire ; Quebec CAX H9R 2X6) Spinney Trevor (3739 St. Dominique Montreal , Method of producing microspheres.
  129. Rasor Julia S. (Cupertino CA) Tickner Ernest G. (Gilroy CA), Method of production and use of microbubble precursors.
  130. Widder Kenneth J. ; Levene Harold B. ; Bales Gary L., Method of ultrasonically quantitating myocardial perfusion using as intravenously injected tracer.
  131. Levene Harold B. (San Diego CA) Villapando Elaine (San Diego CA) Barnhart James L. (Encinitas CA) Widder Kenneth J. (Del Mar CA), Method of ultrasound imaging of the gastrointestinal tract.
  132. Unger Evan C. (Tucson AZ) Yellowhair David W. (Tucson AZ), Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously.
  133. Keana John F. W. (Eugene OR), Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals.
  134. Schutt Ernest G., Methods for harmonic imaging with ultrasound.
  135. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Methods for providing localized therapeutic heat to biological tissues and fluids.
  136. Unger Evan C. (13365 E. Camino La Cebadilla Tucson AZ 85749), Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes.
  137. Quay Steven C. (Los Angeles CA), Methods for selecting and using gases as ultrasound contrast media.
  138. Quay Steven M. (Pacific Palisades CA), Methods for using persistent gases as ultrasound contrast media.
  139. Unger Evan C. (Tucson AZ) Fritz Thomas A. (Tucson AZ) Matsunaga Terry (Tucson AZ) Ramaswami VaradaRajan (Tucson AZ) Yellowhair David (Tucson AZ) Wu Guanli (Tucson AZ), Methods of preparing gas-filled liposomes.
  140. Unger Evan C. (La Cebadilla Tucson AZ 85749), Methoxylated gel particle contrast media for improved diagnostic imaging.
  141. Rasor Julia S. (Cupertino CA) Tickner Ernest G. (Gilroy CA), Microbubble precursors and apparatus for their production and use.
  142. Rasor Julia S. (Cupertino CA) Tickner Ernest G. (Gilroy CA), Microbubble precursors and methods for their production and use.
  143. Klaveness Jo (Oslo NLX) Rongved Pal (Hellvik NLX) Stubberud Lars (Sodertalje NLX), Microbubble-generating contrast agents for ultrasound and magnetic resonance imaging.
  144. Nair Mridula (Penfield NY) Tan Julia S. (Rochester NY), Microgel drug delivery system.
  145. Clark ; Jr. Leland C. (Cincinnati OH), NMR compositions for indirectly detecting a dissolved gas in an animal.
  146. Bara Isabelle (Paris FRX) Mellul Myriam (L\Hay Les Roses FRX), New cosmetic or dermopharmaceutical compositions in the form of aqueous gels modified by the addition of expanded micros.
  147. Grinstaff Mark W. (Pasadena CA) Desai Neil P. (Los Angeles CA) Suslick Kenneth S. (Champaign IL) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Merideth Noma R. (Pacific Palis, Non-fluorinated polymeric shells for medical imaging.
  148. Oraevsky Alexander A. ; Jacques Steven L. ; Esenaliev Rinat O., Optoacoustic imaging for medical diagnosis.
  149. Runge Val M. (Nashville TN) Clanton Jeffrey A. (Nashville TN), Particulate NMR contrast agents for gastrointestinal application.
  150. Wolf Gerald L. (Winchester MA) Long David M. (El Cajon CA), Percutaneous lymphography using particulate fluorocarbon emulsions.
  151. Riess Jean G. (Nice FRX) Greiner Jacques (Nice FRX) Milius Alain (Nice FRX) Vierling Pierre (Nice FRX) Guillod Frederic (Nice FRX) Gaentzler Sylvie (Nice FRX), Perfluorinated amphiphilic phosphorous compounds: liposomal compositions.
  152. Schweighardt Frank K. (Allentown PA) Rubertone Joseph A. (Coatesville PA), Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy of biopsied tissue.
  153. Quay Steven C. (Los Angeles CA), Persistent gaseous bubbles as ultrasound contrast media.
  154. Dingle John T. (Whittlesford GB2) Gordon John L. (Cambridge GB2) Jones Geraint (Macclesfield GB2) Knight Clive G. (Huntingdon GB2) Lowe John S. (Wilmslow GB2), Pharmaceutical compositions.
  155. Gross Udo (Berlin DEX) Roding Joachim (Wiesbaden DEX) Stanzl Klaus (White Plains NY) Zastrow Leonhard (Monaco MCX), Pharmacological composition for topical administration.
  156. Quay Steven C., Phase shift colloids as ultrasound contrast agents.
  157. Quay Steven C., Phase shift colloids as ultrasound contrast agents.
  158. Quay Steven C. (Pacific Palisades CA), Phase shift colloids as ultrasound contrast agents.
  159. Quay Steven C. (Pacific Palisades CA), Phase shift colloids as ultrasound contrast agents.
  160. Moore George G. I. (Afton MN) Flynn Richard M. (Mahtomedi MN) Guerra Miguel A. (Woodbury MN), Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use.
  161. Moore George G. I. (Afton MN) Flynn Richard M. (Mahtomedi MN) Guerra Miguel A. (Woodbury MN), Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use.
  162. Charpiot Brigitte (Nice FRX) Greiner Jacques (Nice FRX) Le Blanc Maurice (Nice FRX) Manfredi Alexandre (Nice FRX) Riess Jean (Falicon FRX) Zarif Leila (Nice FRX), Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants.
  163. Mathiowitz Edith (Brookline MA) Langer Robert S. (Somerville MA) Warshawsky Abraham (Rehovot MA ILX) Edelman Elazar (Brookline MA), Polymer composite for controlled release or membrane formation.
  164. Garner Joseph L. (Sanford MI), Polymerization of styrene acrylonitrile expandable microspheres.
  165. Glajch Joseph L. (Nashua NH) Loomis Gary L. (Drexel Hill PA) Mahler Walter (Wilmington DE), Porous inorganic ultrasound contrast agents.
  166. Millington Arthur R. (Blackburn GB2), Preparation for diagnostic radiology.
  167. Illum Lisbeth (The Park GBX) Johnson Olufunmiloyo Lilly (Cambridge MA), Preparation of microparticles.
  168. Rembaum Alan (Altadena CA) Yen Shiao-Ping S. (Altadena CA) Dreyer William J. (Altadena CA), Preparation of small bio-compatible microspheres.
  169. Leigh Steven (Croydon GB2), Pro-liposome compositions.
  170. Law Say-Jong (Westwood MA) Piran Uri (Sharon MA), Process for forming liposomes.
  171. Baker, Alfred G.; Baker, Andrew J., Process for producing hollow, bilayered silicate microspheres.
  172. Schneider Michel (Grand-Lancy CHX) Lamy Bernard (Carouge CHX), Process for the dehydration of a colloidal dispersion of lipsomes.
  173. Schneider ; Michel, Process for the preparation of liposomes.
  174. Schneider Michel (Geneva CHX), Process for the preparation of liposomes in aqueous solution.
  175. Halliday Pieter S. J. (Randburg ZAX) Harris Allan J. (Knoppigslaagte ZAX), Process for the production of a cartridged explosive with entrapped bubbles.
  176. Lasker Sigmund E. (531 Main St. New York NY 10044), Process for visualizing tissue metabolism using oxygen-17.
  177. Wallach Donald F. H. (Brookline MA), Protein coupling to lipid vesicles.
  178. Sekins K. Michael ; Shaffer Thomas H. ; Wolfson Marla R., Pulmonary delivery of therapeutic agent.
  179. Farmer Martha C. (Washington DC) Beissinger Richard L. (Oak Park IL), Scaled-up production of liposome-encapsulated hemoglobin.
  180. Knight Jack V. (Houston TX) Gilbert Brian E. (Houston TX) Wilson Samuel Z. (Houston TX) Six Howard R. (East Stroudsborg PA) Wyde Philip R. (Houston TX), Small particle aerosol liposome and liposome-drug combinations for medical use.
  181. Martin Francis J. (San Francisco CA) Woodle Martin C. (Menlo Park CA) Redemann Carl (Walnut Creek CA) Yau-Young Annie (Palo Alto CA), Solid tumor treatment method and composition.
  182. Payne Nicholas I. (Wirral GBX) Salmon J. Roger (Wirral GBX), Spray-drying method for preparing liposomes and products produced thereby.
  183. Schutt Ernest G. (San Diego CA) Evitts David P. (La Jolla CA) Kinner Rene Alta (San Diego CA) Anderson Charles David (Lebanon NJ) Weers Jeffry G. (San Diego CA), Stabilized microbubble compositions.
  184. Schutt Ernest G. (San Diego CA) Anderson Charles D. (Lebanon CA) Evitts David P. (La Jolla CA), Stabilized microbubble compositions for ultrasound.
  185. Schneider Michel (Troinex CHX) Brochot Jean (Feigeres FRX) Puginier Jrme (Le Chable-Beaumont FRX) Yan Feng (Meyrin/Geneva CHX), Stable microbubble suspensions as enhancement agents for ultrasound echography.
  186. Schneider Michel (Troinex CHX) Brochot Jean (Feigeres FRX) Puginier Jerome (Le Chable-Beaumont FRX) Yan Feng (Meyrin CHX), Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography.
  187. Schneider Michel (Troinex CHX) Bichon Daniel (Montpellier FRX) Bussat Philippe (Collonge S/Saleve FRX) Puginier Jerome (Le Chable-Beaumont FRX) Hybl-Sutherland Eva (Wiesbaden DEX), Stable microbubbles suspensions injectable into living organisms.
  188. Schneider Michel (Troinex CHX) Bichon Daniel (Montpellier FRX) Bussat Philippe (Collonges S/Saleve FRX) Puginier Jerome (Le Chable-Beaumont FRX) Hybl-Sutherland Eva (Wiesbaden DEX), Stable microbubbles suspensions injectable into living organisms.
  189. Schneider Michel (Troinex CHX) Bichon Daniel (Montpellier FRX) Bussat Philippe (Collonges S/Saleve FRX) Puginier Jerome (Le Chable-Beaumont FRX) Hybl-Sutherland Eva (Wiesbaden DEX), Stable microbubbles suspensions injectable into living organisms.
  190. Schneider Michel (Troinex CHX) Bichon Daniel (Montpellier FRX) Bussat Philippe (Collonges S/Saleve FRX) Puginier Jerome (Le Chable-Beaumont FRX) Hybl-Sutherland Eva (Wiesbaden DEX), Stable microbubbles suspensions injectable into living organisms.
  191. Schneider Michel (Troinex CHX) Bichon Daniel (Montpellier FRX) Bussat Philippe (Collonges S/Saleve FRX) Puginier Jerome (Le Chable-Beaumont FRX) Hybl-Sutherland Eva (Wiesbaden DEX), Stable microbubbles suspensions injectable into living organisms.
  192. Wong Sui-Ming (Collegeville PA) Newington Ian M. (Hazlemere GB2) Liversidge Elaine M. (West Chester PA) McIntire Gregory L. (West Chester PA) Pitt Alan R. (Sandridge GBX) Shaw Jack M. (Aberdeen MD), Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions.
  193. D\Arrigo Joseph S. (23A Brickyard Rd. Farmington CT 06032), Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures.
  194. Porter Thomas R., Suspended ultra-sound induced microbubble cavitation imaging.
  195. Porter Thomas R. (Omaha NE), Suspended ultra-sound induced microbubble cavitation imaging.
  196. Sears Barry D. (Marblehead MA), Synthetic phospholipid compounds.
  197. Unger Evan C. (Tucson AZ) Fritz Thomas A. (Tucson AZ) Matsunaga Terry (Tucson AZ) Ramaswami VaradaRajan (Tucson AZ) Yellowhair David (Tucson AZ) Wu Guanli (Tucson AZ), Therapeutic delivery systems related applications.
  198. Popescu Mircea (Plainsboro NJ) Swenson Christine E. (Plainsboro NJ) Johnson Sterling C. (Skillman NJ) Lenk Robert P. (Lambertville NJ), Therapeutic treatment by intramammary infusion.
  199. Cohrs ; William E. ; Gunderman ; Roland E., Thermoplastic expandable microsphere process and product.
  200. Watmough David J. (Banchary GBX) Mallard John R. (Aberdeen GBX) Hynynen Kullevro (Pyhanta FIX), Ultra sound hyperthermia device.
  201. Reinhardt Michael (Berlin DEX) Fritzsch Thomas (Berlin DEX) Heldmann Dieter (Berlin DEX) Siegert Joachim (Berlin DEX), Ultrasonic contrast agents for color Doppler imaging.
  202. Erbel Raimund (Mainz DEX) Zotz Rainer (Mainz DEX) Krone Volker (Flrsheim DEX) Magerstdt Michael (Hofheim am Taunus DEX) Walch Axel (Frankfurt am Main DEX), Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents.
  203. Erbel Raimund (Mainz DEX) Zotz Rainer (Mainz DEX) Krone Volker (Flrsheim DEX) Magerstdt Michael (Hofheim am Taunus DEX) Walch Axel (Frankfurt am Main DEX), Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents.
  204. Erbel Raimund (Mainz) Zotz Rainer (Mainz) Krone Volker (Flrsheim) Magerstdt Michael (Hofheim am Tanus) Walch Axel (Frankfurt am Main DEX), Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents.
  205. Rasor Ned S. (Cupertino CA) Hilmann Jurgen (Berlin DEX) Lange Lothar (Berlin DEX) Fritzsch Thomas (Berlin DEX) Siegert Joachim (Berlin DEX) Zimmermann Ingfried (Weiler DEX), Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use ther.
  206. Tickner Ernest G. (Morgan Hill CA) Rasor Ned S. (Santa Clara County CA), Ultrasonic image enhancement.
  207. Feinstein Steven B. (295 Hasting Ave. Highland Park IL 60035), Ultrasonic imaging agent and method of preparation.
  208. Schlief Reinhard (Berlin) Poland Hans (Berlin DEX), Ultrasonic manometry process in a fluid by means of microbubbles.
  209. Uhlendorf Volkmar (Berlin DEX) Fritzsch Thomas (Berlin DEX) Siegert Joachim (Berlin DEX), Ultrasonic processes and circuits for performing them.
  210. Quay Steven C. (Pacific Palisades CA), Ultrasound contrast media comprising perfluoropentane and perfluorohexane gas.
  211. Aida Satoshi (Yokohama JPX) Matsumoto Kenzo (Tokyo JPX) Itoh Ayao (Yokohama JPX) Suzuki Yoshinori (Yokohama JPX) Takamizawa Kinya (Yokohama JPX), Ultrasound hyperthermia apparatus.
  212. Schutt Ernest G. (San Diego CA) Anderson Charles D. (Lebanon NJ) Evitts David P. (La Jolla CA), Ultrasound imaging method using microbubbles.
  213. Roberts Mary P. (Newton MA) Gabriel Nancy E. (Wellesley MA), Unilamellar lipid vesicles and method for their formation.
  214. Shell William E. (Los Angeles CA) See Jackie R. (Fullerton CA), Use of biodegradable microspheres labeled with imaging energy constrast materials.
  215. Rosen Gerald M. (Chapel Hill NC), Use of charged nitroxides as NMR image enhancing agents for CSF.
  216. Carson Paul L. (Ann Arbor MI) Detsch Richard M. (Denver CO), Variable frequency gas-bubble-manipulating apparatus and method.
  217. Tin George W. (Arcadia CA), Vesicle stabilization.

이 특허를 인용한 특허 (177)

  1. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  2. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  3. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  4. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  5. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  6. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  7. Niitsu, Yoshiro, Agent for treating myelofibrosis.
  8. Cociorva, Oana; Li, Bei; Szardenings, Anna Katrin; Fukuda, Yasumichi; Nomura, Masahiro; Seto, Shigeki; Yumoto, Kazuhiro; Okada, Kyoko; Nakamura, Ayako, Aminoquinolones as GSK-3 inhibitors.
  9. Gervais,Francine; Kong,Xianqi; Chalifour,Robert; Migneault,David, Amyloid targeting imaging agents and uses thereof.
  10. Lippincott, John; Van Der Horst, Edward Thein Htun; Kim, Sun Young; Presta, Leonard G., Anti-C10orf54 antibodies and uses thereof.
  11. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
  12. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
  13. Hansen, Joshua; Correa, Matthew Daniel; Raheja, Raj; Lopez-Girona, Antonia; Man, Hon-Wah; Muller, George W.; Khalil, Ehab M.; MacBeth, Kyle; Cathers, Brian E.; Pourdehnad, Michael, Antiproliferative compounds and methods of use thereof.
  14. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
  15. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
  16. Liu, Gang, Azolyl urea compounds and methods of use thereof.
  17. Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W., Biaryl acetamide compounds and methods of use thereof.
  18. Song,Young Ho; Welch,Eric D.; Bluni,Scott T., Block copolymer particles.
  19. Takeuchi Yasuhito,JPX, Blood flow blocking method and warming apparatus.
  20. Ballatore, Carlo; Castellino, Angelo J; Smith, III, Amos B; Desharnais, Joel; Sun, Chengzao; Aspland, Simon E, C-10 carbamates of taxanes.
  21. Zhang, Jian; Armer, Thomas A., Cabergoline derivatives.
  22. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Co-enzyme Q10 formulations and methods of use.
  23. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Co-enzyme Q10 formulations and methods of use.
  24. Buiser, Marcia S.; Keenan, Steve; Seehusen, Ashley; Nardone, Christopher, Coil assemblies, components and methods.
  25. Langecker, Peter; Steiert, Matthias; Hino, Toshiaki; Scicinksi, Jan; Paulvannan, Kumarapandian, Composite nanoparticles and uses thereof.
  26. Unger,Evan C., Composition comprising low density microspheres.
  27. Graef, Isabella A.; Alhamadsheh, Mamoun M., Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions.
  28. Graef, Isabella A.; Alhamadsheh, Mamoun M., Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions.
  29. Graef, Isabella A.; Alhamadsheh, Mamoun M., Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions.
  30. Sudhakar, Anantha, Compounds and methods for treatment of cancer.
  31. Cheng, Soan; Comer, Daniel D.; Mao, Long; Balow, Guity P.; Pleynet, David, Compounds and uses thereof in modulating amyloid beta.
  32. Cheng,Soan; Comer,Daniel D.; Mao,Long; Balow,Guity P.; Pleynet,David, Compounds and uses thereof in modulating amyloid beta.
  33. Cheng, Soan; Comer, Daniel D.; Mao, Long; Balow, Guity P.; Pleynet, David, Compounds and uses thereof in modulating amyloid β.
  34. Esposito, Luke A.; Hudson, F. Michael; Lake, Thomas; Cummings, Joel; Weigele, Manfred; Snow, Alan D.; Larsen, Lesley, Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies.
  35. Lindquist, Susan L.; Outeiro, Tiago; Labaudinière, Richard, Compounds, compositions and methods of inhibiting alpha-synuclein toxicity.
  36. Esposito, Luke A.; Hudson, F. Michael; Lake, Thomas; Cummings, Joel; Weigele, Manfred; Snow, Alan D., Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies.
  37. Richard, Robert E., Cross-linked polymer particles.
  38. Li, Bei; Szardenings, Anna Katrin, Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors.
  39. Gordon, Eric M., Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams.
  40. Gordon, Eric M., Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams.
  41. Niitsu, Yoshiro; Kato, Junji; Sato, Yasushi, Drug carrier and drug carrier kit for inhibiting fibrosis.
  42. Niitsu, Yoshiro; Kato, Junji; Sato, Yasushi, Drug carrier and drug carrier kit for inhibiting fibrosis.
  43. Lanphere,Janel L.; McKenna,Erin P.; Naimark,Wendy; Buiser,Marcia S.; Mangin,Stephan P., Drug delivery particle.
  44. Shin, Hyeon-Cheol; Hwang, Hyejeong; Park, Kwang Yong; Kim, Seong Ho; Lee, Haengwoo, Eckol derivatives, methods of synthesis and uses thereof.
  45. Pandey,Ravindra K.; Dougherty,Thomas J.; Pallenberg,Alexander J., Efficient synthesis of pyropheophorbide a and its derivatives.
  46. Buiser, Marcia S.; Seehusen, Ashley; Nardone, Christopher, Embolic coils.
  47. Elliott, Christopher J.; O'Connor, Patrick G., Embolic coils.
  48. Bell, Barbara; Casey, II, Thomas V.; Shaw, William J., Embolic compositions.
  49. Buiser, Marcia; Bellisario, Marc; Knapp, David; Mangin, Stephan; Lanphere, Janel, Embolization.
  50. DiCarlo, Paul; Casey, II, Thomas V.; Mangin, Stephan P., Embolization.
  51. Kamath, Kalpana; Freyman, Toby; Mishra, Shubhang, Embolization.
  52. Lanphere, Janel L.; Buiser, Marcia S.; Casey, Thomas V., Embolization.
  53. Lanphere,Janel; Buiser,Marcia; Casey, II,Thomas V., Embolization.
  54. Rioux, Robert F.; Casey, II, Thomas V.; Lanphere, Janel, Embolization.
  55. Rioux, Robert F.; Casey, II, Thomas V.; Lanphere, Janel L., Embolization.
  56. Davidson,Michael, Enhancement of transfection of DNA into the liver.
  57. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  58. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  59. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  60. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  61. Lanphere, Janel L.; McKenna, Erin P.; Casey, II, Thomas V., Ferromagnetic particles and methods.
  62. Pandey, Ravindra K.; Potter, William R.; Dougherty, Thomas J., Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy.
  63. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  64. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  65. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  66. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  67. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  68. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  69. Baldwin,Samuel P.; Skribiski,Robert P., Forming a chemically cross-linked particle of a desired shape and diameter.
  70. Baldwin,Samuel P.; Skribiski,Robert P., Forming a chemically cross-linked particle of a desired shape and diameter.
  71. Baldwin,Samuel P.; Skribiski,Robert P., Forming a chemically cross-linked particle of a desired shape and diameter.
  72. Buiser, Marcia S.; Lee, Elaine, Forming coils.
  73. Dayton, Paul A.; Sheeran, Paul S.; Matsunaga, Terry O.; Borden, Mark A., Formulation of acoustically activatable particles having low vaporization energy and methods for using same.
  74. McDonald, Ian A.; Turner, Craig Ivan; Deodhar, Mandar; Foot, Jonathan Stuart, Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor.
  75. Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W.; Xu, Shimin, Heterocyclic compounds and methods of use thereof.
  76. Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W.; Xu, Shimin, Heterocyclic compounds and methods of use thereof.
  77. Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W.; Xu, Shimin, Heterocyclic compounds and methods of use thereof.
  78. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  79. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  80. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  81. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  82. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  83. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  84. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
  85. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
  86. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
  87. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
  88. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
  89. Arbogast, Christophe; Bussat, Philippe; Fan, Hong (Helen); Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng, KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy.
  90. Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng, KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy.
  91. Sato, Aaron K.; Sexton, Daniel J.; Dransfield, Daniel T.; Ladner, Robert C.; Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Yan, Feng; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A., KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy.
  92. Sato, Aaron K.; Sexton, Daniel J.; Dransfield, Daniel T.; Ladner, Robert Charles, KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy.
  93. Sato, Aaron K.; Sexton, Daniel J.; Dransfield, Daniel T.; Ladner, Robert Charles; Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng, KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy.
  94. Robinson, Simon P.; Siegler, Robert W.; Onthank, David C.; Nguyen, Nhung Tuyet, Lipid-encapsulated gas microsphere compositions and related methods.
  95. Conston, Stanley R.; Yamamoto, Ronald; Ottoboni, Thomas B.; Tickner, E. Glenn, Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility.
  96. Fraser, Jay, Methods and articles for identifying objects using encapsulated perfluorocarbon tracers.
  97. Estok, Thomas M.; Zaknoen, Sara L.; Mansfield, Robert K.; Lawhon, Tracy, Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders.
  98. Tan, Sharon Mi Lyn, Methods and systems for coating particles.
  99. Janzen, William Perry; Pattenden, Samantha Gail; Jayakody, Chatura Nadisha; Streeter, Jason Eric; Dayton, Paul Alexander; Wood, Cameron Champion; Shenoy, Siddharth Kaup, Methods and systems for using encapsulated microbubbles to process biological samples.
  100. Robinson, Simon P.; Siegler, Robert W.; Nguyen, Nhung Tuyet; Onthank, David C.; Anklekar, Tarakeshwar Vishwanath; Van Kirk, Charles Chester, Methods for making ultrasound contrast agents.
  101. Robinson, Simon P.; Siegler, Robert W.; Nguyen, Nhung Tuyet; Onthank, David C.; Anklekar, Tarakeshwar Vishwanath; Van Kirk, Charles Chester, Methods for making ultrasound contrast agents.
  102. Robinson, Simon P.; Siegler, Robert W.; Nguyen, Nhung Tuyet; Onthank, David C.; Anklekar, Tarakeshwar Vishwanath; Van Kirk, Charles Chester, Methods for making ultrasound contrast agents.
  103. Fan, Hong; Marinelli, Edmund R.; Nanjappan, Palaniappa; Pillai, Radhakrishna; Swenson, Rolf E., Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same.
  104. Narain, Niven Rajin; McCook, John Patrick, Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10).
  105. Fraser, Jay, Methods of delivery of encapsulated perfluorocarbon taggants.
  106. Unger,Evan C.; Wu,Yunqiu, Methods of imaging and treatment.
  107. Narain, Niven Rajin; Sarangarajan, Rangaprasad; Gray, Thomas Mitchell; McCook, John Patrick; Jimenez, Joaquin J., Methods of treatment of cancer by continuous infusion of coenzyme Q10.
  108. Wu, Libo; Zhang, Jian, Methysergide derivatives.
  109. Casey, II, Thomas V.; Damiano, Bud, Mixing and delivery of therapeutic compositions.
  110. Pandey, Ravindra K.; Goswami, Lalit; Spernyak, Joseph; Kanter, Peter; Mazurchuk, Richard, Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents.
  111. Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng; Sato, Aaron K.; Walker, Sharon Michele; Dransfield, Daniel T., Multivalent constructs for therapeutic and diagnostic applications.
  112. Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian; Pillai, Radhakrishna; Pochon, Sibylle; Ramalingam, Kondareddiar; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Sato, Aaron; Walker, Sharon Michele; Dransfield, Daniel T.; Shrivastava, Ajay, Multivalent constructs for therapeutic and diagnostic applications.
  113. Arbogast,Christophe; Bussat,Philippe; Fan,Hong; Linder,Karen E.; Marinelli,Edmund R.; Nanjappan,Palaniappa; Nunn,Adrian; Pillai,Radhakrishna; Pochon,Sibylle; Ramalingam,Kondareddiar; Shrivastava,Ajay; Song,Bo; Swenson,Rolf E.; Von Wronski,Mathew A.; Sato,Aaron; Walker,Sharon Michele; Dransfield,Daniel T., Multivalent constructs for therapeutic and diagnostic applications.
  114. Arbogast,Christophe; Bussat,Philippe; Fan,Hong; Linder,Karen E.; Marinelli,Edmund R.; Nanjappan,Palaniappa; Nunn,Adrian; Pillai,Radhakrishna; Pochon,Sybille; Ramalingam,Kondareddiar; Shrivastava,Ajay, Multivalent constructs for therapeutic and diagnostic applications.
  115. Fan, Hong; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Sato, Aaron K.; Walker, Sharon Michele; Dransfield, Daniel T., Multivalent constructs for therapeutic and diagnostic applications.
  116. Fan, Hong; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Sato, Aaron K.; Walker, Sharon Michele; Dransfield, Daniel T., Multivalent constructs for therapeutic and diagnostic applications.
  117. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Neuromodulatory compounds.
  118. Anderson, Steven M.; Lanphere, Janel, Particles.
  119. DiCarlo, Paul; Lanphere, Janel; Casey, II, Thomas V.; Buiser, Marcia; McKenna, Erin, Particles.
  120. Dransfield, Daniel T.; Sato, Aaron; Ladner, Robert Charles; Nanjappan, Palaniappa, Peptides that specifically bind HGF receptor (CMET) and uses thereof.
  121. Dransfield, Daniel T.; Sato, Aaron K.; Ladner, Robert Charles, Peptides that specifically bind HGF receptor (cMet) and uses thereof.
  122. Dransfield, Daniel T.; Sato, Aaron; Ladner, Robert Charles; Nanjappan, Palaniappa, Peptides that specifically bind HGF receptor (cMet) and uses thereof.
  123. Ly, Tai Wei; Raaum, Erik Dean, Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors.
  124. Hostetler, Karl Y.; Wan, W. Brad, Pharmacologically active agents containing esterified phosphonates and methods for use thereof.
  125. Hostetler, Karl Y.; Wan, W. Brad, Pharmacologically active agents containing esterified phosphonates and methods for use thereof.
  126. Hostetler, Karl Y.; Beadle, James R.; Choo, Hyunah, Phosphono-pent-2-en-1-yl nucleosides and analogs.
  127. Zaveri, Nurulain; Meyer, Michael, Piperdinyl nociceptin receptor compounds.
  128. Lanphere, Janel; St. Pierre, Ernest J.; Kapoglis, Greg; Casey, II, Thomas V., Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient.
  129. Lanphere,Janel L.; Pierre,Ernest J.; Kapoglis,Greg; Casey, II,Thomas V., Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient.
  130. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  131. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  132. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  133. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  134. Daniels, David J.; Parney, Ian F.; Peterson, Timothy E., Pyrazole derivatives as inhibitors of STAT3.
  135. Daniels, David J.; Parney, Ian F.; Peterson, Timothy E., Pyrazole derivatives as inhibitors of STAT3.
  136. Hadd, Michael J.; Holladay, Mark W.; Rowbottom, Martin, Quinazoline compounds and methods of use thereof.
  137. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  138. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  139. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  140. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  141. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  142. Shreder, Kevin; Hu, Yi; Fraser, Allister; Kohno, Yasushi; Kojima, Akihiko; Ishiyama, Junichi, Serine hydrolase inhibitors.
  143. Pang, Yuan-Ping; Park, Jewn Giew; Tang, Jing; Millard, Charles B.; Schmidt, James J., Small-molecule botulinum toxin inhibitors.
  144. Pang, Yuan-Ping; Park, Jewn Giew; Wang, Shaohua; Vummenthala, Anuradha; Mishra, Rajesh K; Davis, Jon; Millard, Charles B.; Schmidt, James J., Small-molecule botulinum toxin inhibitors.
  145. Gross, Timothy David, Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith.
  146. Fernandez, Paul F.; Ferretti, Antonio C.; Kothare, Mohit A.; Li, Ying; Man, Hon-Wah; Zhang, Weihong, Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses.
  147. Coles, Eric; Davidson, Michael, Sonochemical induction of ABCA1 expression and compositions therefor.
  148. Coles, Eric; Davidson, Michael, Sonochemical induction of ABCA1 expression and compositions therefor.
  149. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
  150. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
  151. Zhang, Jian; Cook, Robert O.; Armer, Thomas A.; Kosarev, Sergey Alexandrovich; Xie, Dejian, Substituted indolo 4,3 FG quinolines useful for treating migraine.
  152. Alhamadsheh, Mamoun M.; Park, Miki S.; Chan, William K.; Li, Xiaoling; Penchala, Sravan C.; Miller, Mark R., Systems for stabilizing and delivering active agents.
  153. Dayton, Paul A.; Gessner, Ryan; Lee, Hyunggyun; Lukacs, Marc; Foster, Francis Stuart, Systems, methods, and computer readable media for high frequency contrast imaging and image-guided therapeutics.
  154. Unger,Evan C.; Matsunaga,Terry O.; Schumann,Patricia A., Targeted compositions for diagnostic and therapeutic use.
  155. Niitsu, Yoshiro; Takimoto, Rishu, Targeting agent for cancer cell or cancer-associated fibroblast.
  156. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna K.; Pochon, Sibylle; Song, Bo; Swenson, Rolf E., Targeting vector-phospholipid conjugates.
  157. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna K.; Pochon, Sibylle; Song, Bo; Swenson, Rolf E., Targeting vector-phospholipid conjugates.
  158. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna K.; Pochon, Sibylle; Song, Bo; Swenson, Rolf E., Targeting vector-phospholipid conjugates.
  159. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna; Pochon, Sibylle; Song, Bo; Swenson, Rolf E., Targeting vector-phospholipid conjugates.
  160. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna; Pochon, Sibylle; Song, Bo; Swenson, Rolf E., Targeting vector-phospholipid conjugates.
  161. Niitsu, Yoshiro; Takimoto, Rishu; Minomi, Kenjiro; Miyazaki, Miyono; Kajiwara, Keiko; Tanaka, Yasunobu, Therapeutic agent for pulmonary fibrosis.
  162. Unger,Evan C.; Fritz,Thomas A.; Matsunaga,Terry; Ramaswami,VaradaRajan; Yellowhair,David; Wu,Guanli, Therapeutic delivery systems.
  163. Cheruvallath,Zacharia S.; Loweth,Colin J.; Nutt,Ruth F.; Rideout,Darryl; Semple,Joseph E.; Wang,Jing; Wu,Feiyue; Mylvaganam,Shankari; Zhu,Hengyi; Sun,Jianzhong, Thiazole and thiadiazole inhibitors of tyrosine phosphatases.
  164. Bourne, George; Buiser, Marcia S.; Casey, II, Thomas V.; Keenan, Steve; Lanphere, Janel L.; Li, Jianmin; McKenna, Erin P.; Minasian, Zarouhi; Rao, Doreen, Tissue treatment.
  165. Bourne,George; Buiser,Marcia S.; Casey, II,Thomas V.; Keenan,Steve; Lanphere,Janel L.; Li,Jianmin; McKenna,Erin P.; Minasian,Zarouhi; Rao,Doreen, Tissue treatment.
  166. Lanphere, Janel L.; DiCarlo, Paul; Anderson, Steven M., Tissue-treatment methods.
  167. Lanphere, Janel L.; DiCarlo, Paul; Anderson, Steven M., Tissue-treatment methods.
  168. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Topical co-enzyme Q10 formulations and methods of use.
  169. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Topical co-enzyme Q10 formulations and methods of use.
  170. McCook, John Patrick; Persaud, Indushekhar; Narain, Niven Rajin, Topical formulations having enhanced bioavailability.
  171. Kawabata, Kenichi; Asami, Rei, Ultrasound diagnostic and treatment device.
  172. Unger,Evan C., Ultrasound imaging and treatment.
  173. McGee, Kevin; Zook, Scott; Carr, Andrew; Bonnaud, Thierry, Valbenazine salts and polymorphs thereof.
  174. Pandey, Ravindra K.; Gryshuk, Amy; Goswami, Lalit; Potter, William; Oseroff, Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  175. Pandey,Ravindra K.; Gryshuk,Amy; Goswami,Lalit; Potter,William; Oseroff,Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  176. Cheng, Soan; Comer, Daniel D.; Mao, Long; Balow, Guity P.; Pleynet, David, α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom.
  177. Cheng, Soan; Comer, Daniel D; Mao, Long; Balow, Guity P; Pleynet, David, α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로